Fungal infections of the skin and nail: new treatment options

被引：14
|
作者：
Eldridge, Matthew L. [1 ]
Chambers, Cindy J. [2 ]
Sharon, Victoria R. [2 ]
Thompson, George R., III [1 ,3 ]
机构：
[1] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Med Microbiol & Immunol, Coccidioidomycosis Serol Lab, Davis, CA 95616 USA
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2014年 / 12卷 / 11期
关键词：
antifungal therapy; cutaneous infection; dermatophyte; fluconazole; isavuconazole; itraconazole; posaconazole; voriconazole; CLINICAL-PRACTICE GUIDELINES; DISEASES-SOCIETY; AMPHOTERICIN-B; CRYPTOCOCCUS-GATTII; DOUBLE-BLIND; SUBCUTANEOUS PHEOHYPHOMYCOSIS; ANTIFUNGAL SUSCEPTIBILITIES; ASPERGILLUS SPP; TINEA-CORPORIS; 2007; UPDATE;
D O I：
10.1586/14787210.2014.960849
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Knowledge of the currently available antifungal agents, along with clinical, microbiologic and histopathologic methods, can help the medical professional optimally manage skin and nail fungal infections. With regards to treatment of fungal disease of the skin or nail, there are a variety of systemic antifungal agents, including several newer agents that have different formulations, tolerability, adverse effect profiles and spectrum of activity. This review will highlight the clinically important fungal infections of the skin and nail and describe the activity and role of antifungal treatment.
引用
收藏
页码：1389 / 1405
页数：17
相关论文
共 50 条
12345